CNPFX
Price
$72.67
Change
-$0.24 (-0.33%)
Updated
Oct 9 closing price
Net Assets
164.33B
MGKAX
Price
$14.74
Change
+$0.08 (+0.55%)
Updated
Oct 8 closing price
Net Assets
4.78M
Interact to see
Advertisement

CNPFX vs MGKAX

Header iconCNPFX vs MGKAX Comparison
Open Charts CNPFX vs MGKAXBanner chart's image
American Funds New Perspective 529F
Price$72.67
Change-$0.24 (-0.33%)
VolumeN/A
Net Assets164.33B
Morgan Stanley Global Permanence A
Price$14.74
Change+$0.08 (+0.55%)
VolumeN/A
Net Assets4.78M
CNPFX vs MGKAX Comparison Chart in %
View a ticker or compare two or three
VS
CNPFX vs. MGKAX commentary
Oct 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPFX is a Buy and MGKAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPFX has more cash in the bank: 164B vs. MGKAX (4.78M). MGKAX pays higher dividends than CNPFX: MGKAX (2.24) vs CNPFX (0.62). CNPFX was incepted earlier than MGKAX: CNPFX (23 years) vs MGKAX (6 years). MGKAX (8.22) is less costly to investors than CNPFX (0.84). MGKAX is a more actively managed with annual turnover of: 62.00 vs. CNPFX (24.00). CNPFX has a lower initial minimum investment than MGKAX: CNPFX (250) vs MGKAX (1000). MGKAX annual gain was more profitable for investors over the last year : 16.03 vs. CNPFX (13.08). CNPFX return over 5 years is better than : 36.90 vs. MGKAX (24.01).
CNPFXMGKAXCNPFX / MGKAX
Total Expense Ratio0.841.3562%
Annual Report Gross Expense Ratio0.848.2210%
Fund Existence23 years6 years-
Gain YTD19.72030.66064%
Front LoadN/A5%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets164B4.78M3,432,398%
Annual Yield % from dividends0.622.2428%
Returns for 1 year13.0816.0382%
Returns for 3 years67.0051.52130%
Returns for 5 years36.9024.01154%
Returns for 10 years112.20N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ECX2.330.22
+10.43%
ECARX Holdings
HWKN178.592.46
+1.40%
Hawkins
CMMB3.500.02
+0.43%
Chemomab Therapeutics Ltd
CPSS7.86N/A
N/A
Consumer Portfolio Services
DD78.37-0.51
-0.65%
DuPont de Nemours